Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1) (Q73758272)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 2001

Language	Label	Description	Also known as
English	Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)	scientific article published on 01 May 2001

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304683%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304683%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

C Borgfeldt

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304683%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S R Hansson

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304683%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

B Gustavsson

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304683%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Måsbäck

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304683%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

B Casslén

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304683%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

0 references

publication date

1 May 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304683%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

International Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304683%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

92

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304683%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304683%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

497-502

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304683%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

The plasminogen activation system in tumor growth, invasion, and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue: analysis by Northern blotting and in situ hybridization

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumours

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Regulation of integrin function by the urokinase receptor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine st

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1215

21 January 2018

Identifiers

10.1002/IJC.1215

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304683%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11304683%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73758272&oldid=1911871128"